Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of British Columbia
$120,000.00
Investigating the biological mechanisms of two rare diseases of the immune system, known as inborn errors of immunity
FY 2025-26
Summary
Inborn errors of immunity (IEI) are rare genetic disorders in which mutations lead to components of the human immune system being absent or dysfunctional. My research focuses on two recently discovered IEIs. 1) MSN codes for a protein that allows a type of white blood cell called lymphocytes to multiply and activate immune pathways that defend the body. We have identified four boys with the same MSN mutation who developed severe rashes, recurrent infections, low lymphocyte levels, and lung complications (two of the boys have passed away from this disease). This project will investigate how this mutation affects the amount and function of the protein encoded by MSN. Then, using genetic engineering, I will introduce a normal copy of the MSN gene into patients' lymphocytes, and monitor whether the lymphocytes regain the ability to multiply and function properly. 2) STAT6 allows many types of white blood cells to survive, multiply, and differentiate into specialized types of immune cells. If this gene is overactive, patients develop severe allergic disease, such as eczema, allergic asthma, food allergies, and gastrointestinal complications. We have identified 12 mutations that lead to an overactive STAT6 protein in patients. This project will investigate how these mutations alter healthy functions to drive disease in patients' white blood cells and in genetically engineered cells (in which I create the overactive STAT6 mutations). Finally, I test whether a drug developed to treat patients with overactive STAT6 mutations can restore function in these patients' cells. This research will enhance our understanding of two IEIs and aid in the diagnosis and treatment of affected patients. If we confirm the MSN mutation causes disease, the mutation can be added to tests used to diagnose IEIs, and patients will become eligible for treatment. Our studies of STAT6 disease will not only help treat our patients but also provide insight into common forms of allergic disease.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
560058
Name
Samra Simranjit K
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Investigating the biological mechanisms of two rare diseases of the immune system, known as inborn errors of immunity
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Allergic Disease; Genetics; Immune Dysregulation; Immunodeficiency; Immunology; Inborn Errors Of Immunity; Multi-Omics Research; Precision Medicine; Rare Disease; Translational Research
Abstract
Inborn errors of immunity (IEI) are rare genetic disorders in which mutations lead to components of the human immune system being absent or dysfunctional. My research focuses on two recently discovered IEIs. 1) MSN codes for a protein that allows a type of white blood cell called lymphocytes to multiply and activate immune pathways that defend the body. We have identified four boys with the same MSN mutation who developed severe rashes, recurrent infections, low lymphocyte levels, and lung complications (two of the boys have passed away from this disease). This project will investigate how this mutation affects the amount and function of the protein encoded by MSN. Then, using genetic engineering, I will introduce a normal copy of the MSN gene into patients' lymphocytes, and monitor whether the lymphocytes regain the ability to multiply and function properly. 2) STAT6 allows many types of white blood cells to survive, multiply, and differentiate into specialized types of immune cells. If this gene is overactive, patients develop severe allergic disease, such as eczema, allergic asthma, food allergies, and gastrointestinal complications. We have identified 12 mutations that lead to an overactive STAT6 protein in patients. This project will investigate how these mutations alter healthy functions to drive disease in patients' white blood cells and in genetically engineered cells (in which I create the overactive STAT6 mutations). Finally, I test whether a drug developed to treat patients with overactive STAT6 mutations can restore function in these patients' cells. This research will enhance our understanding of two IEIs and aid in the diagnosis and treatment of affected patients. If we confirm the MSN mutation causes disease, the mutation can be added to tests used to diagnose IEIs, and patients will become eligible for treatment. Our studies of STAT6 disease will not only help treat our patients but also provide insight into common forms of allergic disease.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Samra, Simranjit K
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~